Skip to main content

Table 4 Provider perspectives on the EMR for cancer prevention and screening by survey and study arm

From: Primary care clinicians’ opinions before and after implementation of cancer screening and prevention clinical decision support in a clinic cluster-randomized control trial: a survey research study

  Pre-Implementation Survey Post-Implementation Survey
Survey Questions n UC
n (%)
CDS
n (%)
CDS + SDMT
n (%)
p n UC
n (%)
CDS
n (%)
CDS + SDMT
n (%)
p
Select “yes” or “no” for the following questions on the EMR your clinic uses for screening of breast, cervical, colorectal, or lung cancers or HPV vaccination.
The EMR alerts me that this action is due.
 Breast Cancer Screening 156 56 (96.6) 50 (90.9) 40 (93.0) 0.506a 171 66 (100) 50 (96.2) 51 (96.2) 0.247a
 Pre-post within arm pb   0.217a 0.439a 0.654a       
 Cervical Cancer Screening 155 20 (35.1) 18 (32.7) 12 (27.9) 0.745 172 29 (43.9) 29 (54.7) 23 (43.4) 0.409
 Pre-post within arm pb   0.317 0.021 0.117       
 Colorectal Screening 153 54 (94.7) 49 (90.7) 36 (85.7) 0.310a 172 64 (97.0) 48 (90.6) 49 (92.5) 0.380a
 Pre-post within arm pb   0.662a 0.975 0.329a       
 Lung Screening 153 41 (73.2) 35 (63.6) 21 (50.0) 0.062 169 56 (86.2) 43 (84.3) 40 (75.5) 0.287
 Pre-post within arm pb   0.075 0.016 0.010       
 HPV Vaccination 153 39 (70.9) 44 (80.0) 30 (69.8) 0.429 168 41 (65.1) 37 (71.2) 37 (69.8) 0.758
 Pre-post within arm pb   0.499 0.286 0.996       
The EMR makes it easy for me to order the needed service.
 Breast Cancer Screening 154 49 (87.5) 44 (80.0) 37 (86.1) 0.520 171 58 (87.9) 42 (80.8) 46 (86.8) 0.522
 Pre-post within arm pb   0.949 0.920 0.915       
 Cervical Cancer Screening 153 30 (53.6) 34 (61.8) 28 (66.7) 0.403 170 44 (67.7) 34 (65.4) 36 (67.9) 0.953
 Pre-post within arm pb   0.112 0.702 0.897       
 Colorectal Screening 153 51 (91.1) 40 (74.1) 37 (86.1) 0.048 172 63 (95.5) 45 (84.9) 47 (88.7) 0.130a
 Pre-post within arm pb   0.468a 0.166 0.698       
 Lung Screening 149 42 (75.0) 30 (56.6) 26 (65.0) 0.128 172 57 (86.4) 40 (75.5) 41 (77.4) 0.273
 Pre-post within arm pb   0.110 0.043 0.189       
 HPV Vaccination 148 40 (74.1) 43 (82.7) 30 (71.4) 0.391 167 44 (69.8) 35 (68.6) 36 (67.9) 0.975
 Pre-post within arm pb   0.612 0.960 0.713       
The EMR enables me to print out materials that help patients identify their preferred screening method.
 Breast Cancer Screening 151 18 (32.7) 20 (37.0) 11 (26.2) 0.530 165 17 (26.2) 25 (50.0) 20 (40.0) 0.030
 Pre-post within arm pb   0.430 0.183 0.163       
 Cervical Cancer Screening 149 16 (29.1) 17 (32.1) 9 (22.0) 0.547 165 16 (24.6) 25 (50.0) 16 (32.0) 0.016
 Pre-post within arm pb   0.581 0.064 0.285       
 Colorectal Screening 148 19 (34.6) 22 (43.1) 14 (33.3) 0.548 165 18 (27.7) 26 (52.0) 20 (40.0) 0.029
 Pre-post within arm pb   0.418 0.373 0.509       
 Lung Screening 148 18 (33.3) 18 (34.0) 11 (26.8) 0.726 163 23 (35.9) 26 (52.0) 20 (40.8) 0.220
 Pre-post within arm pb   0.767 0.064 0.164       
 HPV Vaccination 145 20 (38.5) 21 (40.4) 10 (24.4) 0.228 160 17 (26.6) 23 (48.9) 20 (40.8) 0.047
 Pre-post within arm pb   0.172 0.393 0.100       
The EMR makes it easy to calculate cancer risks for individual patients.
 Breast Cancer Screening 152 4 (7.1) 5 (9.1) 3 (7.3) 0.932a 170 8 (12.1) 11 (21.6) 12 (22.6) 0.256
 Pre-post within arm pb   0.544a 0.073 0.051a       
 Cervical Cancer Screening 153 5 (8.9) 4 (7.3) 2 (4.8) 0.861a 170 5 (7.7) 9 (17.3) 9 (17.0) 0.216
 Pre-post within arm pb   0.806 0.144a 0.105a       
 Colorectal Screening 153 6 (10.7) 6 (10.9) 4 (9.5) 1.000a 168 5 (7.7) 8 (15.4) 13 (25.5) 0.031
 Pre-post within arm pb   0.564 0.493 0.061a       
 Lung Screening 151 14 (25.5) 9 (16.4) 6 (14.6) 0.329a 169 15 (22.7) 13 (25.5) 20 (38.5) 0.146
 Pre-post within arm pb   0.726 0.247 0.011       
 HPV Vaccination 152 10 (18.2) 6 (10.9) 3 (7.1) 0.262a 166 6 (9.2) 7 (14.3) 12 (23.1) 0.113
 Pre-post within arm pb   0.151 0.603 0.048a       
  1. Note. Chi-square. Yes responses shown. CDS Clinical Decision Support, SDMT Shared Decision-Making Tool, UC Usual Care
  2. aFisher’s Exact Test
  3. bComparing pre- and post-implementation survey responses within study arms